Ibio Interest Expense vs Interest Income Analysis

IBIO Stock

USD 1.98 0.17 9.39%

Ibio financial indicator trend analysis is infinitely more than just investigating Ibio Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ibio Inc is a good investment. Please check the relationship between Ibio Interest Expense and its Interest Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Interest Expense vs Interest Income

Interest Expense vs Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ibio Inc Interest Expense account and Interest Income. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Ibio's Interest Expense and Interest Income is -0.03. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Interest Income in the same time period over historical financial statements of Ibio Inc, assuming nothing else is changed. The correlation between historical values of Ibio's Interest Expense and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of Ibio Inc are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Interest Expense i.e., Ibio's Interest Expense and Interest Income go up and down completely randomly.

Correlation Coefficient

-0.03

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most indicators from Ibio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ibio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

As of the 18th of May 2024, Selling General Administrative is likely to drop to about 11 M. In addition to that, Discontinued Operations is likely to drop to about (33.7 M)

	2021	2022	2023	2024 (projected)
Gross Profit	2.2M	50K	57.5K	54.6K
Total Revenue	2.4M	50K	57.5K	54.6K

Gross Profit Total Revenue

Ibio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Common Stock Total Equity	Inventory	Net Tangible Assets	Retained Earnings Total Equity
Total Assets		0.68	0.33	0.96	0.83	-0.54	-0.52	0.47	0.89	0.87	0.92	0.86	0.04	0.36	0.64	0.61	0.83	0.83	0.96	-0.17	0.6	0.68	0.58	0.0	0.95	-0.77
Other Current Liab	0.68		0.73	0.67	0.5	-0.17	-0.66	0.78	0.39	0.64	0.47	0.64	0.09	-0.36	0.44	0.69	0.57	0.53	0.63	0.42	0.08	0.55	0.71	0.33	0.63	-0.67
Total Current Liabilities	0.33	0.73		0.28	0.23	0.28	-0.89	0.64	-0.06	0.38	0.0	0.26	0.45	-0.58	0.22	0.87	0.39	0.27	0.26	0.83	-0.38	0.28	0.85	0.8	0.2	-0.7
Total Stockholder Equity	0.96	0.67	0.28		0.68	-0.7	-0.44	0.51	0.91	0.74	0.95	0.89	-0.01	0.32	0.65	0.55	0.64	0.68	0.97	-0.18	0.67	0.54	0.55	-0.06	0.99	-0.68
Property Plant And Equipment Net	0.83	0.5	0.23	0.68		-0.13	-0.36	0.32	0.65	0.98	0.67	0.69	-0.14	0.45	0.3	0.4	0.89	1.0	0.64	-0.27	0.33	0.88	0.29	-0.17	0.68	-0.65
Net Debt	-0.54	-0.17	0.28	-0.7	-0.13		-0.14	-0.18	-0.81	-0.13	-0.81	-0.64	0.2	-0.39	-0.46	0.0	-0.06	-0.12	-0.71	0.45	-0.84	0.05	-0.1	0.38	-0.74	0.08
Retained Earnings	-0.52	-0.66	-0.89	-0.44	-0.36	-0.14		-0.47	-0.19	-0.47	-0.22	-0.31	-0.59	0.27	-0.49	-0.97	-0.61	-0.38	-0.49	-0.61	0.11	-0.33	-0.9	-0.8	-0.36	0.9
Accounts Payable	0.47	0.78	0.64	0.51	0.32	-0.18	-0.47		0.25	0.44	0.32	0.6	-0.1	-0.47	0.14	0.49	0.3	0.35	0.43	0.39	-0.02	0.31	0.52	0.2	0.45	-0.44
Cash	0.89	0.39	-0.06	0.91	0.65	-0.81	-0.19	0.25		0.64	0.99	0.82	-0.1	0.58	0.61	0.3	0.61	0.64	0.93	-0.49	0.85	0.42	0.31	-0.27	0.93	-0.51
Non Current Assets Total	0.87	0.64	0.38	0.74	0.98	-0.13	-0.47	0.44	0.64		0.67	0.73	-0.09	0.33	0.34	0.51	0.9	0.99	0.69	-0.12	0.28	0.9	0.42	-0.06	0.73	-0.72
Cash And Short Term Investments	0.92	0.47	0.0	0.95	0.67	-0.81	-0.22	0.32	0.99	0.67		0.84	-0.1	0.52	0.65	0.33	0.61	0.65	0.95	-0.44	0.83	0.49	0.34	-0.26	0.96	-0.52
Net Receivables	0.86	0.64	0.26	0.89	0.69	-0.64	-0.31	0.6	0.82	0.73	0.84		-0.34	0.26	0.28	0.39	0.58	0.7	0.83	-0.17	0.54	0.45	0.41	-0.21	0.9	-0.58
Common Stock Shares Outstanding	0.04	0.09	0.45	-0.01	-0.14	0.2	-0.59	-0.1	-0.1	-0.09	-0.1	-0.34		-0.21	0.52	0.61	0.13	-0.15	0.11	0.46	-0.07	-0.04	0.61	0.81	-0.08	-0.35
Non Current Liabilities Total	0.36	-0.36	-0.58	0.32	0.45	-0.39	0.27	-0.47	0.58	0.33	0.52	0.26	-0.21		0.17	-0.22	0.31	0.42	0.34	-0.83	0.65	0.28	-0.27	-0.57	0.37	-0.06
Other Current Assets	0.64	0.44	0.22	0.65	0.3	-0.46	-0.49	0.14	0.61	0.34	0.65	0.28	0.52	0.17		0.58	0.47	0.28	0.74	-0.07	0.57	0.35	0.57	0.31	0.63	-0.54
Other Stockholder Equity	0.61	0.69	0.87	0.55	0.4	0.0	-0.97	0.49	0.3	0.51	0.33	0.39	0.61	-0.22	0.58		0.62	0.42	0.59	0.54	0.01	0.35	0.94	0.78	0.47	-0.9
Total Liab	0.83	0.57	0.39	0.64	0.89	-0.06	-0.61	0.3	0.61	0.9	0.61	0.58	0.13	0.31	0.47	0.62		0.89	0.7	-0.09	0.27	0.74	0.49	0.15	0.63	-0.83
Property Plant And Equipment Gross	0.83	0.53	0.27	0.68	1.0	-0.12	-0.38	0.35	0.64	0.99	0.65	0.7	-0.15	0.42	0.28	0.42	0.89		0.64	-0.23	0.3	0.88	0.32	-0.15	0.68	-0.66
Total Current Assets	0.96	0.63	0.26	0.97	0.64	-0.71	-0.49	0.43	0.93	0.69	0.95	0.83	0.11	0.34	0.74	0.59	0.7	0.64		-0.18	0.72	0.48	0.6	0.03	0.96	-0.71
Intangible Assets	-0.17	0.42	0.83	-0.18	-0.27	0.45	-0.61	0.39	-0.49	-0.12	-0.44	-0.17	0.46	-0.83	-0.07	0.54	-0.09	-0.23	-0.18		-0.64	-0.12	0.6	0.81	-0.24	-0.26
Common Stock	0.6	0.08	-0.38	0.67	0.33	-0.84	0.11	-0.02	0.85	0.28	0.83	0.54	-0.07	0.65	0.57	0.01	0.27	0.3	0.72	-0.64		0.15	0.11	-0.39	0.7	-0.15
Property Plant Equipment	0.68	0.55	0.28	0.54	0.88	0.05	-0.33	0.31	0.42	0.9	0.49	0.45	-0.04	0.28	0.35	0.35	0.74	0.88	0.48	-0.12	0.15		0.27	-0.11	0.53	-0.5
Common Stock Total Equity	0.58	0.71	0.85	0.55	0.29	-0.1	-0.9	0.52	0.31	0.42	0.34	0.41	0.61	-0.27	0.57	0.94	0.49	0.32	0.6	0.6	0.11	0.27		0.76	0.48	-0.78
Inventory	0.0	0.33	0.8	-0.06	-0.17	0.38	-0.8	0.2	-0.27	-0.06	-0.26	-0.21	0.81	-0.57	0.31	0.78	0.15	-0.15	0.03	0.81	-0.39	-0.11	0.76		-0.14	-0.51
Net Tangible Assets	0.95	0.63	0.2	0.99	0.68	-0.74	-0.36	0.45	0.93	0.73	0.96	0.9	-0.08	0.37	0.63	0.47	0.63	0.68	0.96	-0.24	0.7	0.53	0.48	-0.14		-0.63
Retained Earnings Total Equity	-0.77	-0.67	-0.7	-0.68	-0.65	0.08	0.9	-0.44	-0.51	-0.72	-0.52	-0.58	-0.35	-0.06	-0.54	-0.9	-0.83	-0.66	-0.71	-0.26	-0.15	-0.5	-0.78	-0.51	-0.63

Click cells to compare fundamentals

Ibio Account Relationship Matchups

Ibio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	94.2M	147.0M	99.4M	41.2M	47.4M	39.2M
Other Current Liab	1.1M	3.0M	3.8M	1.9M	2.2M	1.6M
Total Current Liabilities	5.2M	6.6M	30.4M	21.6M	24.8M	26.1M
Total Stockholder Equity	56.6M	108.6M	63.5M	15.4M	17.7M	19.8M
Property Plant And Equipment Net	31.3M	34.7M	41.8M	7.6M	8.7M	14.0M
Net Debt	(22.2M)	(44.7M)	5.1M	12.8M	11.5M	12.1M
Retained Earnings	(150.4M)	(173.6M)	(223.9M)	(288.9M)	(260.0M)	(247.0M)
Accounts Payable	1.8M	2.3M	4.3M	1.8M	2.1M	1.7M
Cash	55.1M	77.4M	22.7M	4.3M	4.9M	4.7M
Non Current Assets Total	32.4M	42.4M	54.3M	14.9M	17.2M	18.1M
Cash And Short Term Investments	55.1M	97.0M	33.5M	4.3M	4.9M	4.7M
Net Receivables	5.6M	5.5M	6.1M	204K	234.6K	222.9K
Common Stock Shares Outstanding	125.6K	391.2K	17.4K	612.3K	704.1K	739.3K
Liabilities And Stockholders Equity	94.2M	147.0M	99.4M	41.2M	47.4M	39.2M
Non Current Liabilities Total	32.3M	31.8M	5.5M	4.2M	3.8M	3.6M
Other Current Assets	214K	2.1M	(82K)	664K	763.6K	801.8K
Other Stockholder Equity	206.9M	282.1M	287.6M	304.3M	349.9M	367.4M
Total Liab	37.6M	38.4M	35.9M	25.8M	29.7M	18.5M
Property Plant And Equipment Gross	31.3M	34.7M	45.3M	8.2M	9.4M	14.3M
Total Current Assets	61.7M	104.6M	45.1M	26.3M	30.2M	21.1M
Intangible Assets	1.1M	952K	4.9M	5.4M	4.8M	5.1M
Common Stock	16K	20K	140K	217K	9K	21.9K
Property Plant Equipment	3.7M	34.7M	41.8M	7.6M	8.7M	13.8M
Common Stock Total Equity	16K	20K	140K	217K	249.6K	262.0K
Inventory	798K	27K	3.9M	21.1M	24.3M	25.5M
Net Tangible Assets	56.6M	107.6M	58.6M	10.0M	11.5M	10.9M
Short Term Debt	562K	967K	22.3M	13.6M	15.6M	16.4M
Accumulated Other Comprehensive Income	(31K)	(33K)	(63K)	(213K)	(191.7K)	(182.1K)
Short Long Term Debt Total	32.9M	32.7M	27.8M	17.1M	15.4M	21.1M
Current Deferred Revenue	1.8M	423K	100K	4.2M	4.8M	5.1M
Capital Lease Obligations	32.3M	32.1M	5.6M	4.1M	3.7M	3.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Ibio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ibio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Inc Stock:

How To Invest In Ibio

Details

Is Ibio Stock a good investment?

Details

What is Ibio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Ibio Stock analysis

When running Ibio's price analysis, check to measure Ibio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ibio is operating at the current time. Most of Ibio's value examination focuses on studying past and present price action to predict the probability of Ibio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ibio's price. Additionally, you may evaluate how the addition of Ibio to your portfolios can decrease your overall portfolio volatility.

	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Transaction History View history of all your transactions and understand their impact on performance
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Is Ibio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(15.25)

Revenue Per Share

0.044

Quarterly Revenue Growth

(0.88)

Return On Assets

(0.30)

Return On Equity

(1.48)

The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ibio Interest Expense vs Interest Income Analysis

Interest Expense vs Interest Income

Interest Expense vs Interest Income Correlation Analysis

Correlation Coefficient

Interest Expense

Interest Income

Ibio fundamental ratios Correlations

Ibio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ibio fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Ibio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Cash And Short Term Investments	+ 0.99	Cash
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net
Total Current Assets	+ 0.97	Total Stockholder Equity

Other Stockholder Equity	- 0.97	Retained Earnings
Retained Earnings Total Equity	- 0.9	Other Stockholder Equity
Common Stock Total Equity	- 0.9	Retained Earnings
Retained Earnings	- 0.89	Total Current Liabilities
Common Stock	- 0.84	Net Debt
Retained Earnings Total Equity	- 0.83	Total Liab